cergutuzumab
immunoprecipitant
vobarilizumab
alloantibody
sasanlimab
dinutuximab
sintilimab
ziltivekimab
agonistic monoclonal antibody
zenocutuzumab
pozelimab
vanucizumab
solitomab
cedelizumab
toripalimab
retifanlimab
reagin
oportuzumab monatox
monospecific
ublituximab
carlumab
immunopanning
alacizumab
antiantibody
tucotuzumab
-mab
intrabody
elotuzumab
-mul-
sonepcizumab
monoantibody
presentation
immunoproteomics
besilesomab
bursopentine
chromobody
active immunity
antimouse
affinity
antisubstance
ozoralizumab
hyperimmunoglobulin
nerelimomab
talizumab
immunoproteasomal
antigenically
heterophile
immunopeptide
antipolyvalent
patritumab